Disordered T-cell development and T-cell malignancies in SCL LMO1 double-transgenic mice: Parallels with E2A-deficient mice

Molecular and Cellular Biology

Volumn 19, Issue 7, 1999, Pages 5025-5035

  Chervinsky, David S ^a   Zhao, Xian Feng ^a   Lam, Du H ^a   Ellsworth, Marykay ^a   Gross, Kenneth W ^a   Aplan, Peter D ^a,b  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b CHILDREN S HOSPITAL OF BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CLONE; CELL MATURATION; CELL PROLIFERATION; CELL VIABILITY; CHROMOSOME REARRANGEMENT; CONTROLLED STUDY; LEUKEMOGENESIS; LYMPHOMA; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T CELL LEUKEMIA; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; THYMOCYTE; THYMUS; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS; RODENTIA;

EID: 0033043388     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.7.5025     Document Type: Article

References (49)

1. Aplan, P. D., C. G. Begley, V. Bertness, M. Nussmeier, A. Ezquerra, J. Coligan, and I. R. Kirsch. 1990. The SCL gene is formed from a transcriptionally complex locus. Mol. Cell. Biol. 10:6426-6435.
2. Aplan, P. D., C. A. Jones, D. S. Chervinsky, X. Zhao, M. Ellsworth, C. Wu, E. A. McGuire, and K. W. Gross. 1997. An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice. EMBO J. 16: 2408-2419.
3. Aplan, P. D., D. P. Lombardi, A. M. Ginsberg, J. Cossman, V. I. Bertness, and I. R. Kirsch. 1990. Disruption of the human SCL locus by "illegitimate" V-(D)-J recombinase activity. Science 250:1426-1429.
4. Aplan, P. D., D. P. Lombardi, and I. R. Kirsch. 1991. Structural characterization of SIL, a gene frequently disrupted in T-cell acute lymphoblastic leukemia. Mol. Cell. Biol. 11:5462-5469.
5. Bain, G., I. Engel, E. C. Robanus-Maandag, H. P. te Riele, J. R. Voland, L. I. Sharp, J. Chun, B. Huey, D. Pinkel, and C. Murre. 1997. E2A deficiency leads to abnormalities in α/β T-cell development and to rapid development of T-cell lymphomas. Mol. Cell. Biol. 17:4782-4791.
6. Bash, R. O., W. M. Crist, J. J. Shuster, M. P. Link, M. Amylon, J. Pullen, A. J. Carroll, G. R. Buchanan, R. G. Smith, and R. Baer. 1993. Clinical features and outcome of T-cell acute lymphoblastic leukemia in childhood with respect to alterations at the TAL1 locus: a Pediatric Oncology Group study. Blood 81:2110-2117.
7. Bash, R. O., S. Hall, C. F. Timmons, W. M. Crist, M. Amylon, R. G. Smith, and R. Baer. 1995. Does activation of the TAL1 gene occur in a majority of patients with T-cell acute lymphoblastic leukemia? A Pediatric Oncology Group study. Blood 86:666-676.
8. Begley, C. G., P. D. Aplan, M. P. Davey, K. Nakahara, K. Tchorz, J. Kurtzberg, M. S. Hershfield, B. F. Haynes, D. I. Cohen, T. A. Waldmann, and I. R. Kirsch. 1989. Chromosomal translocation in a human leukemic stem-cell line disrupts the T-cell antigen receptor delta-chain diversity region and results in a previously unreported fusion transcript. Proc. Natl. Acad. Sci. USA 86:2031-2035.
9. Begley, C. G., P. D. Aplan, S. M. Denning, B. F. Haynes, T. A. Waldmann, and I. R. Kirsch. 1989. The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif. Proc. Natl. Acad. Sci. USA 86:10128-10132.
10. Brown, L., J. T. Cheng, Q. Chen, M. J. Siciliano, W. Crist, G. Buchanan, and R. Baer. 1990. Site-specific recombination of the tal-1 gene is a common occurrence in human T cell leukemia. EMBO J. 9:3343-3351.
11. Burd, R., T. S. Dziedzic, Y. Xu, M. A. Caligiuri, J. R. Subjeck, and E. A. Repasky. 1998. Tumor cell apoptosis, lymphocyte recruitment and tumor vascular changes are induced by low temperature, long duration (fever-like) whole body hyperthermia. J. Cell. Physiol. 177:137-147.
12. Chen, Q., J. T. Cheng, L. H. Tasi, N. Schneider, G. Buchanan, A. Carroll, W. Crist, B. Ozanne, M. J. Siciliano, and R. Baer. 1990. The tal gene undergoes chromosome translocation in T cell leukemia and potentially encodes a helix-loop-helix protein. EMBO J. 9:415-424.
13. Cheng, J. T., H. L. Hsu, L. Y. Hwang, and R. Baer. 1993. Products of the TAL1 oncogene: basic helix-loop-helix proteins phosphorylated at serine residues. Oncogene 8:677-683.
14. Collazo-Garcia, N, P. Scherer, and P. D. Aplan. 1995. Cloning and characterization of a murine SIL gene. Genomics 30:506-513.
15. Condorelli, G. L., F. Facchiano, M. Valtieri, E. Proietti, L. Vitelli, V. Lulli, K. Huebner, C. Peschle, and C. M. Croce. 1996. T-cell-directed TAL-1 expression induces T-cell malignancies in transgenic mice. Cancer Res. 56: 5113-5119.
16. Dedera, D. A., E. K. Waller, D. P. LeBrun, A. Sen-Majumdar, M. E. Stevens, G. S. Barsh, and M. L. Cleary. 1993. Chimeric homeobox gene E2A-PBX1 induces proliferation, apoptosis, and malignant lymphomas in transgenic mice. Cell 74:833-843.
17. Elefanty, A. G., C. G. Begley, D. Metcalf, L. Barnett, F. Kontgen, and L. Robb. 1997. Characterization of hematopoietic progenitor cells that express the transcription factor scl, using a lacZ knock-in strategy. Proc. Natl. Acad. Sci. USA 95:11897-11902.
18. Finger, L. R., J. Kagan, G. Christopher, J. Kurtzberg, M. S. Hershfield, P. C. Nowell, and C. M. Croce. 1989. Involvement of the TCL5 gene on human chromosome 1 in T-cell leukemia and melanoma. Proc. Natl. Acad. Sci. USA 86:5039-5043.
19. Fitzgerald, T. J. G. A. Neale, S. C. Raimondi, and R. M. Goorha. 1991. c-tal, a helix-loop-helix protein, is juxtaposed to the T-cell receptor-beta chain gene by a reciprocal chromosomal translocation: t(1;7)(p32;q35). Blood 78: 2686-2695.
20. Gering, M., A. R. F. Rodaway, B. Gottgens, R. K. Patient, and A. R. Green. 1998. The scl gene specifies haemangioblast development from early mesoderm. EMBO J. 17:4029-4045.
21. Goldfarb, A. N., S. Goueli, D. Mickelson, and J. M. Greenberg. 1992. T-cell acute lymphoblastic leukemia - the associated gene SCL/tal codes for a 42-Kd nuclear phosphoprotein. Blood 80:2858-2866.
22. Goldfarb, A. N., K. Lewandowska, and M. Shoham. 1996. Determinants of helix-loop-helix dimerization affinity. Random mutational analysis of SCL/tal. J. Biol. Chem. 271:2683-2688.
23. Grutz, G. G., K. Bucher, I. Lavenir, T. Larson, R. Larson, and T. Rabbitts. 1998. The oncogenic T cell LIM-protein LMO2 forms part of a DNA-binding complex specifically in immature T cells. EMBO J. 17:4594-4605.
24. Hsu, H. L., J. T. Cheng, Q. Chen, and R. Baer. 1991. Enhancer-binding activity of the tal-1 oncoprotein in association with the E47/E12 helix-loop-helix proteins. Mol. Cell. Biol. 11:3037-3042.
25. Hsu, H. L., L. Huang, J. T. Tsan, W. Funk, W. E. Wright, J. S. Hu, R. E. Kingston, and R. Baer. 1994. Preferred sequences for DNA recognition by the TAL1 helix-loop-helix proteins. Mol. Cell. Biol. 14:1256-1265.
26. Kelliher, M. A., D. C. Seldin, and P. Leder. 1996. Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIalpha. EMBO J. 15: 5160-5166.
27. Larson, R. C, I. Lavenir, T. A. Larson, R. Baer, A. J. Warren, I. Wadman, K. Nottage, and T. H. Rabbitts. 1996. Protein dimerization between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice. EMBO J. 15:1021-1027.
28. Larson, R. C., H. Osada, T. A. Larson, I. Lavenir, and T. H. Rabbitts. 1995. The oncogenic LIM protein Rbtn2 causes thymic developmental aberrations that precede malignancy in transgenic mice. Oncogene 11:853-862.
29. Lowsky, R., J. F. Decoteau, A. H. Reitmair, R. Ichinohasama, W. F. Dong, Y. Xu, T. W. Mak, M. E. Kadin, and M. D. Minden. 1997. Defects of the mismatch repair gene Msh2 are implicated in the development of murine and human lymphoblastic lymphomas and are associated with the aberrant expression of rhombotin-2 (Lmo-2) and Tal-1 (Scl). Blood 89:2276-2282.
30. McGuire, E. A., C. E. Rintoul, G. M. Sclar, and S. J. Korsmeyer. 1992. Thymic overexpression of Ttg-1 in transgenic mice results in T-cell acute lymphoblastic leukemia/lymphoma. Mol. Cell. Biol. 12:4186-4196.
31. Murre, C., P. S. McCaw, and D. Baltimore. 1989. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell 56:777-783.
32. - lymphocytes in the thymus and T-cell tumors in transgenic mice. Blood 86:3060-3071.
33. Ordentlich, P., A. Lin, C. P. Shen, C. Blaumueller, K. Matsuno, S. Artavanis-Tsakonas, and T. Kadesch. 1998. Notch inhibition of E47 supports the existence of a novel signaling pathway. Mol. Cell. Biol. 18:2230-2239.
34. Park, S. T., and X. H. Sun. 1998. The Tal1 oncoprotein inhibits E47-mediated transcription - mechanism of inhibition. J. Biol. Chem. 273:7030-7037.
35. Rabbitts, T. H. 1994. Chromosomal translocations in human cancer. Nature 372:143-149.
36. Robb, L., I. Lyons, R. Li, L. Hartley, F. Kontgen, R. P. Harvey, D. Metcalf, and C. G. Begley. 1995. Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene. Proc. Natl. Acad. Sci. USA 92:7075-7079.
37. Robb, L., J. E. Rasko, M. L. Bath, A. Strasser, and C. G. Begley. 1995. scl, a gene frequently activated in human T cell leukaemia, does not induce lymphomas in transgenic mice. Oncogene 10:205-209.
38. Robey, E., D. Chang, A. Itano, D. Cado, H. Alexander, D. Lans, G. Weinmaster, and P. Salmon. 1996. An activated form of Notch influences the choice between CD4 and CD8 T cell lineages. Cell 87:483-492.
39. Sanchez-Garcia, I., and T. H. Rabbitts. 1994. Transcriptional activation by TAL1 and FUS-CHOP proteins expressed in acute malignancies as a result of chromosomal abnormalities. Proc. Natl. Acad. Sci. USA 91:7869-7873.
40. Sawada, S., and D. R. Littman. 1993. A heterodimer of Heb and an E12-related protein interacts with the CD4 enhancer and regulates its activity in T-cell lines. Mol. Cell. Biol. 13:5620-5628.
41. Shivdasani, R. A., E. L. Mayer, and S. H. Orkin. 1995. Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL. Nature 373:432-434.
42. Stanulla, M., J. Wang, D. S. Chervinsky, S. Thandla, and P. D. Aplan. 1997. DNA cleavage within the MLL breakpoint cluster region is a specific event which occurs as part of higher-order chromatin fragmentation during the initial stages of apoptosis. Mol. Cell. Biol. 17:4070-4079.
43. Thandla, S., and P. D. Aplan. 1997. Molecular biology of acute lymphocytic leukemia. Semin. Oncol. 24:45-56.
44. Visvader, J. E., Y. Fujiwara, and S. H. Orkin. 1998. Unsuspected role for the T-cell leukemia protein SCL/tal-1 in vascular development. Genes Dev. 12:473-479.
45. Voronova, A. F., and F. Lee. 1994. The E2A and tal-1 helix-loop-helix proteins associate in vivo and are modulated by Id proteins during interleukin 6-induced myeloid differentiation. Proc. Natl. Acad. Sci. USA 91:5952-5956.
46. Wadman, I., J. Li, R. O. Bash, A. Forster, H. Osada, T. H. Rabbitts, and R. Baer. 1994. Specific in vivo association between the bHLH and LIM proteins implicated in human T cell leukemia. EMBO J. 13:4831-4839.
47. Wadman, I. A., H. Osada, G. G. Grutz, A. D. Agulnick, H. Westphal, A. Forster, and T. H. Rabbitts. 1997. The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins. EMBO J. 16:3145-3157.
48. Yan, W., A. Z. Young, V. C. Soares, R. Kelley, R. Benezra, and Y. Zhuang. 1997. High incidence of T-cell tumors in E2A-null mice and E2A/Id1 double-knockout mice. Mol. Cell. Biol. 17:7317-7327.
49. Zhao, X.-F., and P. D. Aplan. 1999. The hematopoietic transcription factor SCL binds the p44 subunit of TFIIH. J. Biol. Chem. 274:1388-1393.